Patton Fund Management, Inc. Incyte Corp Transaction History

Patton Fund Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $171,376 - $214,564	2,551 New	2,551 $204,000
Q4 2020 Jan 29, 2021	SELL	$80.74 - $97.7 $1.38 Million - $1.67 Million	-17,109 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$85.07 - $109.69 $683,197 - $880,920	8,031 Added 88.47%	17,109 $1.54 Million
Q2 2020 Jul 08, 2020	SELL	$74.18 - $108.93 $120,245 - $176,575	-1,621 Reduced 15.15%	9,078 $944,000
Q1 2020 Apr 15, 2020	SELL	$63.18 - $85.97 $2.16 Million - $2.95 Million	-34,258 Reduced 76.2%	10,699 $783,000
Q4 2019 Jan 24, 2020	BUY	$73.04 - $95.72 $3.28 Million - $4.3 Million	44,957 New	44,957 $3.93 Million

659

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.